Global Neurostimulation Devices Market 2015

神経刺激装置の世界市場:脊髄電気刺激、脳深部刺激、仙椎神経刺激、迷走神経刺激

◆タイトル:Global Neurostimulation Devices Market 2015
◆商品コード:IRTNTR6144
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年6月17日
◆ページ数:85
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、神経刺激装置の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、神経刺激装置の世界市場規模及び予測、装置種類別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Neurostimulation Devices
Available pharmacological treatment for conditions such as chronic pain, epilepsy, Parkinson’s disease, and depression are not sufficient for all patients at all stages of treatment. More than 100 million people suffer from these conditions in the US alone. Though drug therapy, physiotherapy, and surgeries are effective treatment options, they are not suitable for all patients. For example, approximately 15-20% of epilepsy patients are drug-resistant and require alternate treatment method. Neurostimulation is a potential alternative for patients for whom the drug therapy or surgery is not effective.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson’s disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

Technavio’s analysts forecast the global neurostimulation devices market to grow at a CAGR of 5.37% over the period 2014-2019.

[Covered in this Report]
The report covers the present scenario and the growth prospects of the global neurostimulation devices market for the period 2015-2019. Based on devises, the market can be segmented into the following: SCS systems, DBS systems, SNS systems, VNS systems, and others.
Technavio’s report, Global Neurostimulation Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the global neurostimulation devices market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Boston Scientific
• Cyberonics
• Medtronic
• St. Jude Medical

[Other Prominent Vendors]
• Aleva Neurotherapeutics
• Atrotech
• Autonomic Technologies
• ElectroCore
• Endostim
• EnteroMedics
• ImThera Medical
• Inspire Medical Systems
• Neuros Medical
• NeuroMetrix
• NeuroPace
• NeuroSigma
• Nevro
• SPR Therapeutics
• Synapse Biomedical

[Market Driver]
• Rise in Prevalence of Neurological Disorders
• For a full, detailed list, view our report

[Market Challenge]
• Not First Line of Treatment Therapy
• For a full, detailed list, view our report

[Market Trend]
• Significant Increase in Product Development and Launches
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction
05.1 Basic Components of Neurostimulation Devices
05.2 Generator
05.3 Leads
05.4 Programmer

06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Rechargeable and Non-rechargeable Neurostimulation Devices
06.4 Five Forces Analysis

07.Market Segmentation by Systems
07.1 Global SCS Systems Market
07.1.1 Market Size and Forecast
07.2 Global DBS Systems Market
07.2.1 Market Size and Forecast
07.3 Global SNS Systems Market
07.3.1 Market Size and Forecast
07.4 Global VNS Systems Market
07.4.1 Market Size and Forecast

08.Geographical Segmentation
08.1 Neurostimulation Devices Market in Americas
08.1.1 Market Size and Forecast
08.2 Neurostimulation Devices Market in EMEA
08.2.1 Market Size and Forecast
08.3 Neurostimulation Devices Market in the APAC
08.3.1 Market Size and Forecast

09.Buying Criteria

10.Market Growth Drivers

11.Drivers and their Impact

12.Market Challenges

13.Impact of Drivers and Challenges

14.Market Trends

15.Trends and their Impact

16.Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Market Share Analysis 2014
16.3 Other Prominent Vendors

17.Key Vendor Analysis
17.1 Medtronic
17.1.1 Key Facts
17.1.2 Business Overview
17.1.3 Business Segmentation
17.1.4 Revenue by Business Segmentation
17.1.5 Revenue Comparison by Business Segmentation 2012 and 2013
17.1.6 Revenue by Geographical Segmentation
17.1.7 Business Strategy
17.1.8 Key Developments
17.1.9 SWOT Analysis
17.2 Boston Scientific
17.2.1 Key Facts
17.2.2 Business Overview
17.2.3 Business Segmentation
17.2.4 Business Segmentation by Revenue 2013
17.2.5 Business Segmentation by Revenue 2012 and 2013
17.2.6 Geographical Segmentation by Revenue 2013
17.2.7 Business Strategy
17.2.8 Recent Developments
17.2.9 SWOT Analysis
17.3 St. Jude Medical
17.3.1 Key Facts
17.3.2 Business Description
17.3.3 Business Segmentation
17.3.4 Business Strategy
17.3.5 Revenue Segmentation by Business
17.3.6 Revenue by Geographical Segmentation
17.3.7 Key Information
17.3.8 SWOT Analysis
17.4 Cyberonics
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Geographical Segmentation by Revenue 2014
17.4.4 Business Strategy
17.4.5 Recent Developments
17.4.6 SWOT Analysis

18.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Components of Neurostimulation Devices
Exhibit 3: Global Neurostimulation Devices Market 2014-2019 ($ Millions)
Exhibit 4: Segmentation of Global Neurostimulation Devices Market by Systems
Exhibit 5: Segmentation of Global Neurostimulation Devices Market by Systems 2014
Exhibit 6: Global SCS Systems Market 2014-2019 ($ Millions)
Exhibit 7: Cost Distribution in Parkinson’s Disease
Exhibit 8: Global DBS Systems Market 2014-2019 ($ Millions)
Exhibit 9: Global SNS Systems Market 2014-2019 ($ Millions)
Exhibit 10: Global VNS System Market 2014-2019 ($ Millions)
Exhibit 11: Segmentation of Global Neurostimulation Devices Market by Systems 2014-2019
Exhibit 12: Segmentation of Global Neurostimulation Devices Market by Systems 2014-2019 ($ Millions)
Exhibit 13: Snapshot of Global Neurostimulation Devices Market 2014-2019
Exhibit 14: Segmentation of Global Neurostimulation Devices Market by Geography in 2014
Exhibit 15: Common Conditions That Use Neurostimulation Devices
Exhibit 16: Disease Economic Burden in the US
Exhibit 17: Neurostimulation Devices Market in the Americas 2014-2019 ($ Millions)
Exhibit 18: Neurostimulation Devices Market in EMEA 2014-2019 ($ Millions)
Exhibit 19: Neurostimulation Devices Market in APAC 2014-2019 ($ Millions)
Exhibit 20: Segmentation of Global Neurostimulation Devices Market by Geography in 2014-2019
Exhibit 21: Segmentation of Global Neurostimulation Devices Market by Geography in 2014-2019 ($ Millions)
Exhibit 22: Global Neurostimulation Devices Market Share Analysis 2014
Exhibit 23: Key Takeaways: Medtronic
Exhibit 24: Key Takeaways: Boston Scientific
Exhibit 25: Key Takeaways: St. Jude Medical
Exhibit 26: Key Takeaways: Cyberonics
Exhibit 27: Medtronic Inc.: Business Segmentation
Exhibit 28: Medtronic Inc.: Revenue by Business Segmentation 2013
Exhibit 29: Medtronic Inc.: Revenue Comparison by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 30: Medtronic Inc.: Revenue by Geographical Segmentation 2013
Exhibit 31: Boston Scientific: Business Segmentation
Exhibit 32: Boston Scientific: Business Segmentation by Revenue 2013
Exhibit 33: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 34: Boston Scientific: Geographical Segmentation by Revenue 2013
Exhibit 35: St. Jude Medical: Business Segmentation
Exhibit 36: St. Jude Medical: Revenue by Business Segmentation 2013
Exhibit 37: St. Jude Medical: Revenue by Geographical Segmentation 2012
Exhibit 38: Cyberonics: Geographical Segmentation by Revenue 2014



【掲載企業】

Boston Scientific, Cyberonics, Medtronic, St. Jude Medical, Aleva Neurotherapeutics, Atrotech, Autonomic Technologies, ElectroCore, Endostim, EnteroMedics, ImThera Medical, Inspire Medical Systems, Neuros Medical, NeuroMetrix, NeuroPace, NeuroSigma, Nevro, SPR Therapeutics, Synapse Biomedical


【資料のキーワード】

神経刺激装置、脊髄電気刺激、脳深部刺激、仙椎神経刺激、迷走神経刺激、医療機器、治療

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[神経刺激装置の世界市場:脊髄電気刺激、脳深部刺激、仙椎神経刺激、迷走神経刺激] (Global Neurostimulation Devices Market 2015 / IRTNTR6144)販売に関する免責事項
[神経刺激装置の世界市場:脊髄電気刺激、脳深部刺激、仙椎神経刺激、迷走神経刺激] (Global Neurostimulation Devices Market 2015 / IRTNTR6144)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆